Results

Total Results: 892 records

Showing results for "end stage renal".

841. Evidence-based Practice Center Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ongoing-studies-evidence_research.pdf
     December 01, 2010 - to suggest factors that might predict relevance and utility of the completed study and associated end-products … when compared to the trial registration, and only 45 percent of studies were registered before the end … While many of these registries are no longer in existence, they likely set the stage for current clinical … Additionally, the time frame 20 examined in this project is at an early stage when trial registration … Type II Diabetes and the Metabolic Syndrome and on Inflammatory Bowel Disease, Rheumatoid Arthritis, Renal

842. Evidence Summary: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/statin-use-in-adults-preventive-medication
     August 23, 2022 - Asselbergs FW, Diercks GF, Hillege HL, et al; Prevention of Renal and Vascular Endstage Disease Intervention … Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type … : 26 a Daily aspirin use: 17 ALLHAT-LLT    Furberg et al, 2002 18    (Fair) Aged ≥55 y with stage … Evaluation of Rosuvastatin; MI, myocardial infarction; NR, not reported; PREVEND-IT, Prevention of Renal

843. Sampling, Weighting, and Synthetization Methodologies (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-Sampling-Weighting-Synthetization-Methodologies.pdf
     December 01, 2023 - For Medicare, the coverage qualification reasons were “End-stage renal disease (ESRD),” “Disability … Discharge Status The discharge status describes the status of the person as of the service end date

844. Rapid Response: Efficacy of Dental Services for Reducing Adverse Events in Those Receiving Chemotherapy for Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-response-chemotherapy-dental.pdf
     July 01, 2023 - oral or dental examination performed on an inpatient basis as part of comprehensive workup prior to renal … the body’s immune system, leading to impairment of resistance to infections and other disorders.7 Renal … reviewer was unsure regarding the appropriate disposition of a study (either at the abstract or full-text stage … Response, a thorough search of the MEDLINE database compiled all relevant published studies through the end … Evidence-based Practice Center (EPC) Program using streamlined literature review methods to assist end-users

845. Continuous-Outcomes-Quantitative-Synthesis Methods (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/continuous-outcomes-quantitative-synthesis_methods.pdf
     March 01, 2011 - The summary of final key points and recommendations are presented in Table 2 at the end of this chapter … The two end points of IQR and range are not symmetric around median (or mean) if the distribution of … Allowing for uncertainty due to missing data in meta- analysis--part 1: two-stage methods. … alter the conclusions of a meta-analysis with continuous outcomes: a case study of changes in renal … monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal

846. 8 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
     November 01, 2008 - outcomes data, including data that showed no difference in gastrointestinal adverse events at the end … Development of instruments for assessing risk of bias specifically in studies of harms is still in an early stage … Adverse Effects of Cyclooxygenase 2 Inhibitors on Renal and Arrhythmia Events: Meta-analysis of

847. 8 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
     November 01, 2008 - outcomes data, including data that showed no difference in gastrointestinal adverse events at the end … Development of instruments for assessing risk of bias specifically in studies of harms is still in an early stage … Adverse Effects of Cyclooxygenase 2 Inhibitors on Renal and Arrhythmia Events: Meta-analysis of

848. ADHD Medications and Risk of Serious Coronary Heart Disease in Yough and Middle-Aged Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
     January 01, 2023 - other than non-melanoma skin cancer), HIV infection, organ transplant, liver failure or hepatic coma, end-stage … renal disease, respiratory failure, or severe congestive heart failure. … included to reduce the potential for misclassification and referred to the first 30 days after the end … The former use category began after indeterminate use ended (i.e., at 31 days after end of current use … of insurance coverage/pharmacy benefit, day before 65th birthday, or end of study period (December

849. Home and Community-Based Services Quality Indicators: (pdf file)
     qualityindicators.ahrq.gov/Downloads/Resources/Publications/2012/Appendix_1A_Details_of_literature_review.pdf
     January 01, 2012 - References cited are listed at the end of each section. … One quarter of pressure ulcers in people with SCI are classified as severe (stage III or IV) (Caliri … However, as BMI increased, the prevalence of higher stage PU increased, suggesting that high BMI may … • Treatment strategies in geriatric populations should vary according to the stage of ulcer development … patients experienced multi-organ dysfunction with neurological impairment (100%), moderate-to-severe renal

850. Disposition of Comments: Technical Brief 37 Prevention, Diagnosis, and Management of Opioids, Opioid Misuse, and Opioid Use Disorder in Older Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-37-opiod-use-adults-comments.pdf
     November 03, 2020 - factors associated with opioid use, and opioid-related harms and adverse outcomes are included at the end … Next Steps Several future areas of research are identified at the end of each section throughout the … assume long-term opioid use is automatically bad, and because policymakers do not always read to the end … I am now at Stage II Renal Failure. … of ersatz expected utility model you embrace- but you lack the honesty to state clearly what your end

851. Abnormal-Uterine-Bleeding Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
     March 01, 2013 - • Who are healthy, and without renal impairment, hepatic impairment, intestinal disease, thyroid

852. Type-2-Diabetes-Medications-Update Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
     December 31, 2013 - pioglitazone at baseline (228 mg/dl), and for placebo plus pioglitazone at baseline (236 mg/dl) and end … No clinically significant changes in renal function. … Glimepiride(sulfo nylureas) with metformin RCT 68 normoalbuminuric type 2 diabetes patients 1 year Renal … A total of 39.2 (exenatide) vs. 20.8% (insulin) of patients reached the composite end point of A1C … Yale, 201345 Canagliflozin Placebo RCT 269 subjects with type 2 diabetes and stage 3 chronic kidney

853. Making Healthcare Safer Practices: 15. Care Transitions (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/care-transitions-1.pdf
     March 01, 2020 - Evaluation of BOOST implementation in the second cohort of hospitals occurred via mid-year and end-year … common chronic illnesses (i.e., all primary diagnoses except neurological disorders or cancer, end-stage … renal disease, and untreated psychiatric disorders) in Aetna’s Medicare Advantage program in the

854. Strategies to Improve Patient Safety: Draft Report to Congress for Public Comment and Review by the National Academy of Medicine (pdf file)
     pso.ahrq.gov/sites/default/files/wysiwyg/strategies-to-improve-patient-safety_draft-report.pdf
     December 21, 2021 - of process where the event originated, and stage of process where the event originated by patient … of process where event originated, and stage of process where event originated by patient harm. … By the end of 2000, Congress directed $50 million to AHRQ to support patient safety research and improvement … Engagement Patient Safety Practices MHS I (2001) MHS II (2013) MHS III (2020) Advance Planning For End-of-Life … health and hospice, long- term care, mental health, pediatrics, pharmacy, radiology, rehabilitation, renal

855. 2001 HCUP Nationwide Inpatient Sample (NIS) Comparison Report
     hcup-us.ahrq.gov/db/nation/nis/reports/2001niscomparisonrpt.jsp
     November 01, 2015 - The remaining sample of hospitals was based on a stratified, three-stage design: During the first … The second stage consisted of selecting non-certainty hospitals from the sampled PSUs. … At the third stage, a sample of discharges was selected by systematic random sampling techniques. … At the other end of the spectrum, only two of the ten least populous states were included in the NIS: … 0.01) 1.01* 6.76 (0.06) 6.85 2.93 (0.11) 3.12 $23,701 (460) $22,790* 316: Renal

856. Microsoft Word - Deliverable #94.10 - Final 2001 NIS Comparison Report 10-2. (pdf file)
     hcup-us.ahrq.gov/reports/methods/NIS_Comparison_Report_2001.pdf
     January 01, 2001 - The remaining sample of hospitals was based on a stratified, three-stage design: • During the first … • The second stage consisted of selecting non-certainty hospitals from the sampled PSUs. … • At the third stage, a sample of discharges was selected by systematic random sampling techniques … At the other end of the spectrum, only two of the ten least populous states were included in the NIS … 134 (3) 114** 0.98 (0.01) 1.01* 6.76 (0.06) 6.85 2.93 (0.11) 3.12 $23,701 (460) $22,790* 316: Renal

857. 2003 HCUP Nationwide Inpatient Sample (NIS) Comparison Report
     hcup-us.ahrq.gov/db/nation/nis/reports/2003niscomparisonrpt.jsp
     May 01, 2016 - The remaining sample of hospitals was based on a stratified, three-stage design: The first stage … The second stage consisted of selecting non-certainty hospitals from the sampled PSUs. … During the third and final stage, a sample of discharges was selected by systematic random sampling techniques … At the other end of the spectrum, only four of the 10 least populous states were included in the NIS: … (0.02) 1.29* 6.12 (0.05) 6.23* 0.00 (0.00) 0.00 1 $25,643 (711) $25,362 316: renal

858. Infantile-Hemangioma Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_executive.pdf
     January 01, 2016 - were typically not severe, only one comparative study29 had greater than 6 months followup after the end … report use of steroids and laser treatments in younger children with lesions in the proliferative stage … SACRAL syndrome: spinal dysraphism, anogenital, cutaneous, renal and urologic anomalies, associated

859. Fielding the CAHPS Cancer Care Survey (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cancer/fielding-cancer-53.pdf
     July 14, 2017 - case during the different rounds of data collection; the final result code reflects the status at the end … Contact the person again before the end of data collection to determine if he/she has recovered and … (s) 52355* Cystourethroscopy, with ureteroscopy and/or pyeloscopy; with resection of ureteral or renal … 44141 Colectomy, partial; with skin level cecostomy or colostomy 44143 Colectomy, partial; with end … removal of terminal ileum with ileocolostomy 44206 Laparoscopy, surgical; colectomy, partial, with end

860. Kbjjfcap9Xvhkp43U-7B9Q (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/KbJjfcaP9XvhkP43u-7b9q
     July 01, 2014 - Ann Intern Med. 2014;161:31-45. doi:10.7326/M13-2837 www.annals.org For author affiliations, see end … Child–Pugh score, separately and in combination with spontaneous bacterial peritonitis with sepsis, renal … Poor-quality studies did not address at least 4 of 5 key confounders (age, sex, fibrosis stage, HBV viral … Changes in liver histology as a “surrogate” end point of antiviral therapy for chronic HBV can predict … history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end